Literature DB >> 10551628

Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging.

G J Parker1, P S Tofts.   

Abstract

Pharmacokinetic analysis using dynamic magnetic resonance imaging provides insight into various physiological aspects of tumors, including capillary wall permeability and the volume of the interstitial space. This physiology may be investigated in either a heuristic or model-based fashion using various methods presented in the literature. This review describes many of these approaches and provides some guidelines for those intending to use dynamic magnetic resonance imaging in the investigation of neoplasms.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10551628     DOI： 10.1097/00002142-199904000-00006

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN： 0899-3459


  13 in total

Review 1.  Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment.

Authors:  Marc A Bjurlin; Xiaosong Meng; Julien Le Nobin; James S Wysock; Herbert Lepor; Andrew B Rosenkrantz; Samir S Taneja
Journal:  J Urol       Date:  2014-04-21       Impact factor: 7.450

Review 2.  Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

Authors:  Jayashree Kalpathy-Cramer; Elizabeth R Gerstner; Kyrre E Emblem; Ovidiu Andronesi; Bruce Rosen
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

3.  Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features.

Authors:  W W Yao; H Zhang; B Ding; T Fu; H Jia; L Pang; L Song; W Xu; Q Song; K Chen; Z Pan
Journal:  Radiol Med       Date:  2011-02-01       Impact factor: 3.469

4.  Magnetic Resonance Imaging of Human Tissue-Engineered Adipose Substitutes.

Authors:  Maryse Proulx; Kim Aubin; Jean Lagueux; Pierre Audet; Michèle Auger; Marc-André Fortin; Julie Fradette
Journal:  Tissue Eng Part C Methods       Date:  2015-02-25       Impact factor: 3.056

Review 5.  Applications of molecular MRI and optical imaging in cancer.

Authors:  Marie-France Penet; Maria Mikhaylova; Cong Li; Balaji Krishnamachary; Kristine Glunde; Arvind P Pathak; Zaver M Bhujwalla
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

6.  The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach.

Authors:  B Nicolas Bloch; Robert E Lenkinski; Neil M Rofsky
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

7.  Feasibility of using limited-population-based average R10 for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced magnetic resonance imaging data.

Authors:  Wei Huang; Ya Wang; David M Panicek; Lawrence H Schwartz; Jason A Koutcher
Journal:  Magn Reson Imaging       Date:  2009-03-17       Impact factor: 2.546

8.  Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging.

Authors:  Nancy J Fischbein; Susan M Noworolski; Roland G Henry; Michael J Kaplan; William P Dillon; Sarah J Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

9.  Magnetic Resonance Imaging Parameters and Their Impact on Survival of Patients with Glioblastoma: Tumor Perfusion Predicts Survival.

Authors:  Bob L Hou; Sijin Wen; Gennadiy A Katsevman; Hui Liu; Ogaga Urhie; Ryan C Turner; Jeffrey Carpenter; Sanjay Bhatia
Journal:  World Neurosurg       Date:  2018-12-27       Impact factor: 2.104

10.  Molecular imaging in oncology.

Authors:  A S K Dzik-Jurasz
Journal:  Cancer Imaging       Date:  2004-10-21       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.